UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Fisher Asset Management LLC

Fisher Asset Management LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 3.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,197,167 shares of the healthcare conglomerate’s stock after buying an additional 107,097 shares during the period. Fisher Asset Management LLC owned approximately 0.35% of UnitedHealth Group worth $1,869,320,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Daiwa Securities Group Inc. raised its holdings in UnitedHealth Group by 16.1% in the third quarter. Daiwa Securities Group Inc. now owns 208,493 shares of the healthcare conglomerate’s stock valued at $121,902,000 after acquiring an additional 28,850 shares in the last quarter. Marco Investment Management LLC increased its holdings in shares of UnitedHealth Group by 0.3% in the 3rd quarter. Marco Investment Management LLC now owns 36,665 shares of the healthcare conglomerate’s stock valued at $21,437,000 after acquiring an additional 120 shares during the period. Summit Trail Advisors LLC grew its holdings in shares of UnitedHealth Group by 13.5% during the third quarter. Summit Trail Advisors LLC now owns 13,631 shares of the healthcare conglomerate’s stock worth $7,970,000 after buying an additional 1,623 shares during the last quarter. Cahill Financial Advisors Inc. raised its stake in shares of UnitedHealth Group by 6.1% during the third quarter. Cahill Financial Advisors Inc. now owns 4,676 shares of the healthcare conglomerate’s stock worth $2,734,000 after purchasing an additional 270 shares during the last quarter. Finally, Capital Investment Counsel LLC increased its stake in shares of UnitedHealth Group by 7.4% during the third quarter. Capital Investment Counsel LLC now owns 14,151 shares of the healthcare conglomerate’s stock worth $8,274,000 after acquiring an additional 973 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently commented on the stock. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. UBS Group decreased their price target on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. Royal Bank of Canada lowered their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating for the company in a research note on Wednesday, October 16th. Finally, Barclays reduced their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 22nd. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Trading Down 1.1 %

Shares of UnitedHealth Group stock opened at $590.87 on Monday. The firm has a 50-day moving average of $582.63 and a 200-day moving average of $553.30. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The stock has a market cap of $543.77 billion, a PE ratio of 38.49, a PEG ratio of 1.73 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping the consensus estimate of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company’s quarterly revenue was up 9.2% on a year-over-year basis. During the same period in the prior year, the company earned $6.56 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.